← Back to signals
VRTX
STRONG BUYVertex Pharmaceuticals Inc.
Health Care
0.67
PEGY ratio
Rank #247
Why This Matters
This stock appears significantly undervalued relative to its growth and dividend yield. Strong projected growth of 42.1% annually over 5 years.
VRTX is trading at 28.1x earnings against 42.1% growth (no dividend), giving a PEGY of 0.67. The math suggests the stock is significantly undervalued relative to its growth and income profile.
~ Growth estimate uses historical CAGR (forward estimates unavailable)
- • Growth rate derived from historical CAGR — limited analyst coverage.
Scan date: 2026-04-24
Valuation
28.1x
P/E Ratio
Growth
42.1%
5yr EPS
Income
0.0%
Div Yield
PEGY Components
PEGY Score0.67
Denominator42.1%
EPS (TTM)$15.32
Market Data
Price$430.29
ExchangeNASDAQ
S&P 500Nasdaq 100
What Changed
PEGY Score
0.68→0.67(-0.01)
Rank
#185→#247(62 positions)
vs 7 days ago
Portfolio Context
Founder does not hold this stock.
Not in your portfolio.
Sector: Health Care
PEGY History — 90 days
Data: Yahoo Finance • Updated nightly 11 PM ET • For informational purposes only